carmustine
Aliases
BCNU
5 clinical trials
3 abstracts
6 indications
Indication
lymphomaIndication
Hodgkin LymphomaIndication
Glioblastoma MultiformeIndication
AdultIndication
GlioblastomaIndication
Supratentorial GliosarcomaClinical trial
A Phase II Trial Of BEAM/Rituximab/Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Patients With CD20 Positive Non-Hodgkin's LymphomaStatus: Completed, Estimated PCD: 2005-11-01
Abstract
Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas.Org: Dana-Farber Cancer Institute and Harvard Medical School,
Abstract
Repurposing hemostatic drug desmopressin in AVPR2-expressing triple-negative breast cancer: Target expression analysis and preclinical antineoplastic effects on tumor growth and metastatic progression.Org: Center of Translational Medicine, El Cruce “Néstor Kirchner” Hospital, Montefiore Einstein Comprehensive Cancer Center/Albert Einstein College of Medicine, Center for Molecular and Translational Oncology (COMTra), Science and Technology Department, National University of Quilmes, Provincial Institute for Cancer Prevention and Treatment (IPC),
Clinical trial
Phase I Study of Yttrium-90 Labeled Anti-CD25 (a-Tac) Monoclonal Antibody Plus BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma, the "a-Tac BEAM Regimen"Status: Active (not recruiting), Estimated PCD: 2021-07-24
Clinical trial
High Dose Chemotherapy and Combination Anti-HIV Therapy for HIV-Associated Hodgkin's and Non-Hodgkin's LymphomaStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Clinical trial
Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect HematopoiesisStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Phase II Trial of Rituxan and BEAM High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Transplant for LymphomaStatus: Completed, Estimated PCD: 2002-01-01
Abstract
Preapproval medical products in patients with the diagnosis of metastatic uveal melanoma.Org: Sidney Kimmel Cancer at Jefferson Health, Sidney Kimmel Medical College at Thomas Jefferson University, NYU Grossman School of Medicine – Division of Medical Ethics, NYU Grossman School of Medicine- Division of Medical Ethics, Sidney Kimmel Cancer Center at Thomas Jefferson University,